Effects of a Standardized Phenolic-Enriched Maple Syrup Extract on β-Amyloid Aggregation, Neuroinflammation in Microglial and Neuronal Cells, and β-Amyloid Induced Neurotoxicity in Caenorhabditis elegans

Neurochemical Research

Volumn 41, Issue 11, 2016, Pages 2836-2847

  Ma, Hang ^a   DaSilva, Nicholas A ^a   Liu, Weixi ^a   Nahar, Pragati P ^a   Wei, Zhengxi ^a   Liu, Yongqiang ^a   Pham, Priscilla T ^b   Crews, Rebecca ^b   Vattem, Dhiraj A ^b,c   Slitt, Angela L ^a   Shaikh, Zahir A ^a   Seeram, Navindra P ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b TEXAS STATE UNIVERSITY   (United States)

^c OHIO UNIVERSITY   (United States)

Author keywords

Alzheimer s disease; Amyloid 1 42; Caenorhabditis elegans; Maple syrup phenolics; Neuroinflammation; Neuroprotective

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; INTERLEUKIN 6; MAPLE SYRUP EXTRACT; NEUROPROTECTIVE AGENT; PLANT EXTRACT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; LIPOPOLYSACCHARIDE; PHENOL DERIVATIVE; POLYPHENOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING ASSAY; CAENORHABDITIS ELEGANS; CELL VIABILITY; CIRCULAR DICHROISM; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAPLE SYRUP; MICROGLIA; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; PLANT; PRIORITY JOURNAL; PROTEIN AGGREGATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ACER; ANIMAL; CELL SURVIVAL; CHEMISTRY; COCULTURE; DRUG EFFECTS; METABOLISM; MOUSE; TOXICITY AND INTOXICATION;

ACER; AMYLOID BETA-PEPTIDES; ANIMALS; CAENORHABDITIS ELEGANS; CELL SURVIVAL; COCULTURE TECHNIQUES; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; PHENOLS; POLYPHENOLS;

EID: 84978858036     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-016-1998-6     Document Type: Article

References (42)

1. Praticò D, Trojanowski JQ (2000) Inflammatory hypotheses: novel mechanisms of Alzheimer’s neurodegeneration and new therapeutic targets? Neurobiol Aging 21:441–445
2. Block ML, Zecca L, Hong J-S (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69
3. Heneka MT, O’Banion MK (2007) Inflammatory processes in Alzheimer’s disease. J Neuroimmunol 184:69–91
4. Alzheimer’s Association (2013) 2013 Alzheimer’s disease facts and figures. Alzheimers Dement 9:208–245
5. Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S (2002) The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health 23:213–231
6. Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185
7. Haass C, Selkoe DJ (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75:1039–1042
8. Herrmann N, Chau SA, Kircanski I, Lanctôt KL (2011) Current and emerging drug treatment options for Alzheimer’s disease. Drugs 71:2031–2065
9. Vellas B, Pesce A, Robert PH, Aisen PS, Ancoli-Israel S, Andrieu S, Cedarbaum J, Dubois B, Siemers E, Spire J-P (2011) AMPA workshop on challenges faced by investigators conducting Alzheimer’s disease clinical trials. Alzheimers Dement 7:e109–e117
10. Kim J, Lee HJ, Lee KW (2010) Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem 112:1415–1430
11. Willis LM, Shukitt-Hale B, Joseph JA (2009) Recent advances in berry supplementation and age-related cognitive decline. Curr Opin Clin Nutr Metab Care 12:91–94
12. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL (2005) A potential role of the curry spice curcumin in Alzheimer’s disease. Curr Alzheimer Res 2:131–136
13. Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A (2013) Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies. ACS Cheml Neurosci 4:973–982
14. Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM (2008) Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. J Neurosci 28:6388–6392
15. Liu RH (2013) Dietary bioactive compounds and their health implications. J Food Sci 78(Suppl 1):A18–A25
16. Ball DW (2007) The chemical composition of maple syrup. J Chem Edu 84:1647–1650
17. Abou-Zaid MM, Nozzolillo C, Tonon A, Coppens M, Lombardo DA (2008) High-performance liquid chromatography characterization and identification of antioxidant polyphenols in maple syrup. Pharm Biol 46:117–125
18. Li L, Seeram NP (2010) Maple syrup phytochemicals include lignans, coumarins, a stilbene, and other previously unreported antioxidant phenolic compounds. J Agric Food Chem 58:11673–11679
19. Li L, Seeram NP (2011) Further investigation into maple syrup yields 3 new lignans, a new phenylpropanoid, and 26 other phytochemicals. J Agric Food Chem 59:7708–7716
20. Hawco CL, Wang Y, Taylor M, Weaver DF (2016) A Maple Syrup extract prevents β-amyloid aggregation. Can J Neurol Sci 43(1):198–201
21. Aaron C, Beaudry G, Parker JA, Therrien M (2016) Maple syrup decreases TDP-43 proteotoxicity in a Caenorhabditis elegans model of amyotrophic lateral sclerosis (ALS). J Agric Food Chem 64:3338–3344
22. Zhang Y, Yuan T, Li L, Nahar P, Slitt A, Seeram NP (2014) Chemical compositional, biological, and safety studies of a novel maple syrup derived extract for nutraceutical applications. J Agric Food Chem 62:6687–6698
23. Nahar PP, Driscoll MV, Li L, Slitt AL, Seeram NP (2014) Phenolic mediated anti-inflammatory properties of a maple syrup extract in RAW 264.7 murine macrophages. J Funct Foods 6:126–136
24. Yuan T, Ma H, Liu W, Niesen DB, Shah N, Crews R, Rose KN, Vattem DA, Seeram NP (2016) Pomegranate’s neuroprotective effects against Alzheimer’s disease are mediated by urolithins, iIts ellagitannin-gut microbial derived metabolites. ACS Chem Neurosci 7:26–33
25. Das S, Stark L, Musgrave IF, Pukala T, Smid SD (2016) Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity. Food Funct 7:1138–1146
26. Shoval H, Weiner L, Gazit E, Levy M, Pinchuk I, Lichtenberg D (2008) Polyphenol-induced dissociation of various amyloid fibrils results in a methionine-independent formation of ROS. Biochim Biophys Acta 1784:1570–1577
27. Vetri V, Canale C, Relini A, Librizzi F, Militello V, Gliozzi A, Leone M (2007) Amyloid fibrils formation and amorphous aggregation in concanavalin A. Biophys Chem 125:184–190
28. Song X, Wei Z, Shaikh ZA (2015) Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells. Toxicol Appl Pharmacol 287:26–34
29. Dowling P, Clynes M (2011) Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers. Proteomics 11:794–804
30. Wang S, Wang H, Guo H, Kang L, Gao X, Hu L (2011) Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation. Neuroscience 185:150–160
31. Liu R-P, Zou M, Wang J-Y, Zhu J-J, Lai J-M, Zhou L-L, Chen S-F, Zhang X, Zhu J-H (2014) Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling. J Neuroinflamm 11:47
32. Feng Y, Wang X-P, Yang S-G, Wang Y-J, Zhang X, Du X-T, Sun X-X, Zhao M, Huang L, Liu R-T (2009) Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 30:986–995
33. Dai X, Hou W, Sun Y, Gao Z, Zhu S, Jiang Z (2015) Chitosan oligosaccharides inhibit/disaggregate fibrils and attenuate amyloid β-mediated neurotoxicity. Int J Mol Sci 16:10526–10536
34. Zhong L-M, Zong Y, Sun L, Guo J-Z, Zhang W, He Y, Song R, Wang W-M, Xiao C-J, Lu D (2012) Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PloS One 7:e32195
35. Shih Y-T, Chen I-J, Wu Y-C, Lo Y-C (2011) San-Huang-Xie-Xin-Tang protects against activated microglia- and 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. Evid Based Complement Alternat Med 2011:429384
36. Cohen E, Dillin A (2008) The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci 9:759–767
37. Radak Z, Zhao Z, Goto S, Koltai E (2011) Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA. Mol Aspects Med 32:305–315
38. Shukla V, Mishra SK, Pant HC (2011) Oxidative stress in neurodegeneration. Adv Pharmacol Sci 1043:545–552
39. de Fátima Bezerra M, Jamison BY, Gomada Y, Borges KC, Correia RTP, Vattem DA (2014) Eugenia jambolana Lam. Increases lifespan and ameliorates experimentally induced neurodegeneration in C. elegans. Int J Appl Res Nat Prod 7:39–48
40. Azevêdo JC, Borges KC, Genovese MI, Correia RT, Vattem DA (2015) Neuroprotective effects of dried camu-camu (Myrciaria dubia HBK McVaugh) residue in C. elegans. Food Res Int 73:135–141
41. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, Link CD, Luo Y (2006) Amyloid-β-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26:13102–13113
42. Dostal V, Roberts CM, Link CD (2010) Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicity. Genetics 186:857–866